Search
National Health Investors Inc
NHIAdd to Watchlist
70.910USD
+0.090+0.13%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
3.44BMarket Cap
22.79P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of National Health Investors Inc is 7.50, ranking 59 out of 190 in the Residential & Commercial REITs industry. The average price target is 87.50, with a high of 90.00 and a low of 77.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
84.750
Target Price
+19.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
8
Median
9
Average
Company name
Ratings
Analysts
National Health Investors Inc
NHI
8
Digital Realty Trust Inc
DLR
33
Equinix Inc
EQIX
33
American Tower Corp
AMT
25
VICI Properties Inc
VICI
25
Gaming and Leisure Properties Inc
GLPI
24
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is National Health Investors Inc's expected revenue for the next quarter?
National Health Investors Inc's expected revenue is 109.80M.
What is National Health Investors Inc's price target?
Analysts forecast that National Health Investors Inc's price target is USD 87.50, with the highest forecast at USD 90.00 and the lowest forecast at USD 77.00.
How have National Health Investors IncNHI's recent earnings per share performed?
The market expectation was USD 0.83, while National Health Investors IncNHI's earnings per share (EPS) for the previous quarter was USD 0.80. EPS for the next quarter is expected at USD 0.87.
What is the analyst rating for National Health Investors Inc?
Based on the ratings of National Health Investors Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
